Randomized controlled trial to compare safety and efficacy of mycophenolate vs. cyclosporine after rituximab in children with steroid-resistant nephrotic syndrome.

Farahnak AssadiMojgan MazaheriSimin Sadeghi-Bodj

Published in: Pharmacotherapy (2022)

MMF-RTX is superior to CYC-RTX in maintaining remission with fewer AEs in children with initial SRNS. Additional high-quality randomized control trials with long-term follow-up are needed to identify the long-term potential complications.

Keyphrases

randomized controlled trial
young adults
study protocol
open label
double blind
risk factors
phase iii
rheumatoid arthritis
disease activity
risk assessment
human health
hodgkin lymphoma